Identification
Name Miglitol
Accession Number DB00491 (APRD01117)
Type small molecule
Description Miglitol is an oral anti-diabetic drug that acts by inhibiting the ability of the patient to breakdown complex carbohydrates into glucose. It is primarily used in diabetes mellitus type 2 for establishing greater glycemic control by preventing the digestion of carbohydrates (such as disaccharides, oligosaccharides, and polysaccharides) into monosaccharides which can be absorbed by the body. Miglitol inhibits glycoside hydrolase enzymes called alpha-glucosidases. Since miglitol works by preventing digestion of carbohydrates, it lowers the degree of postprandial hyperglycemia. It must be taken at the start of main meals to have maximal effect. Its effect will depend on the amount of non-monosaccharide carbohydrates in a person's diet. In contrast to acarbose (another alpha-glucosidase inhibitor), miglitol is systemically absorbed; however, it is not metabolized and is excreted by the kidneys.
Structure
Categories (*)
Molecular Weight 207.2243
Groups approved
Monoisotopic Weight 207.110672659
Pharmacology
Indication For use as an adjunct to diet to improve glycemic control in patients with non-insulin-dependent diabetes mellitus (NIDDM) whose hyperglycemia cannot be managed with diet alone.
Mechanism of action In contrast to sulfonylureas, miglitol does not enhance insulin secretion. The antihyperglycemic action of miglitol results from a reversible inhibition of membrane-bound intestinal a-glucoside hydrolase enzymes. Membrane-bound intestinal a-glucosidases hydrolyze oligosaccharides and disaccharides to glucose and other monosaccharides in the brush border of the small intestine. In diabetic patients, this enzyme inhibition results in delayed glucose absorption and lowering of postprandial hyperglycemia.
Absorption Absorption of miglitol is saturable at high doses with 25 mg being completely absorbed while a 100-mg dose is only 50-70% absorbed. No evidence exists to show that systemic absorption of miglitol adds to its therapeutic effect.
Protein binding The protein binding of miglitol is negligible (<4.0%).
Biotransformation Miglitol is not metabolized in man or in any animal species studied.
Route of elimination Miglitol is not metabolized in man or in any animal species studied. It is eliminated by renal excretion as an unchanged drug.
Toxicity Unlike sulfonylureas or insulin, an overdose will not result in hypoglycemia. An overdose may result in transient increases in flatulence, diarrhea, and abdomi-nal discomfort. Because of the lack of extra-intestinal effects seen with miglitol, no serious systemic reactions are expected in the event of an overdose.
Affected organisms
  • Humans and other mammals
Interactions
Drug Interactions
Drug Mechanism of interaction
Glucosamine Possible hyperglycemia
Somatropin recombinant Somatropin may antagonize the hypoglycemic effect of miglitol. Monitor for changes in fasting and postprandial blood sugars.
Food Interactions
  • Take with food, at beginning of each meal. Iron needs increased.
Maltase-glucoamylase, intestinal
Name Maltase-glucoamylase, intestinal
Gene Name MGAM
Pharmacological action yes
Actions antagonist,inhibitor
References
  • Mooradian AD, Thurman JE: Drug therapy of postprandial hyperglycaemia. Drugs. 1999 Jan;57(1):19-29. - Pubmed
  • Rossi EJ, Sim L, Kuntz DA, Hahn D, Johnston BD, Ghavami A, Szczepina MG, Kumar NS, Sterchi EE, Nichols BL, Pinto BM, Rose DR: Inhibition of recombinant human maltase glucoamylase by salacinol and derivatives. FEBS J. 2006 Jun;273(12):2673-83. - Pubmed
  • Fukaya N, Mochizuki K, Tanaka Y, Kumazawa T, Jiuxin Z, Fuchigami M, Goda T: The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats. Eur J Pharmacol. 2009 Dec 10;624(1-3):51-7. Epub 2009 Oct 7. - Pubmed
  • Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. - Pubmed
DTHybrid score 1.3023
Lysosomal alpha-glucosidase
Name Lysosomal alpha-glucosidase
Gene Name GAA
Pharmacological action yes
Actions antagonist
References
  • Fukaya N, Mochizuki K, Tanaka Y, Kumazawa T, Jiuxin Z, Fuchigami M, Goda T: The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats. Eur J Pharmacol. 2009 Dec 10;624(1-3):51-7. Epub 2009 Oct 7. - Pubmed
  • Hirata A, Igarashi M, Iwai H, Tominaga M: Effect of miglitol, an alpha-glucosidase inhibitor, on atherogenic outcomes in balloon-injured diabetic rats. Horm Metab Res. 2009 Mar;41(3):213-20. Epub 2008 Dec 15. - Pubmed
DTHybrid score 0.8558
Neutral alpha-glucosidase AB
Name Neutral alpha-glucosidase AB
Gene Name Not Available
Pharmacological action yes
Actions antagonist
References
  • Fukaya N, Mochizuki K, Tanaka Y, Kumazawa T, Jiuxin Z, Fuchigami M, Goda T: The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats. Eur J Pharmacol. 2009 Dec 10;624(1-3):51-7. Epub 2009 Oct 7. - Pubmed
  • Hirata A, Igarashi M, Iwai H, Tominaga M: Effect of miglitol, an alpha-glucosidase inhibitor, on atherogenic outcomes in balloon-injured diabetic rats. Horm Metab Res. 2009 Mar;41(3):213-20. Epub 2008 Dec 15. - Pubmed
DTHybrid score Not Available
Neutral alpha-glucosidase C
Name Neutral alpha-glucosidase C
Gene Name Not Available
Pharmacological action yes
Actions antagonist
References
  • Fukaya N, Mochizuki K, Tanaka Y, Kumazawa T, Jiuxin Z, Fuchigami M, Goda T: The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats. Eur J Pharmacol. 2009 Dec 10;624(1-3):51-7. Epub 2009 Oct 7. - Pubmed
  • Hirata A, Igarashi M, Iwai H, Tominaga M: Effect of miglitol, an alpha-glucosidase inhibitor, on atherogenic outcomes in balloon-injured diabetic rats. Horm Metab Res. 2009 Mar;41(3):213-20. Epub 2008 Dec 15. - Pubmed
DTHybrid score Not Available
Pancreatic alpha-amylase
Name Pancreatic alpha-amylase
Gene Name AMY2A
Actions Not Available
References Not Available
DTHybrid score 1.586
Id Partner name Gene Name Score
2129 Sucrase-isomaltase, intestinal SI 0.3011
3030 Salivary alpha-amylase AMY1A 0.1716
4622 Amylase Not Available 0.0841
2978 Maltogenic alpha-amylase amyM 0.0816
4830 Aldose 1-epimerase galM 0.0492
5012 Ig lambda chain V-II region MGC Not Available 0.0132
4385 Cytochrome c' Not Available 0.0132
4967 Cytochrome c' cycA 0.0132
5038 Cytochrome c' Not Available 0.0132
5223 Cytochrome c' cycP 0.0132
5036 Small inducible cytokine A8 CCL8 0.0132
5023 Glycoside hydrolase Not Available 0.0116
5024 Glycoside hydrolase Not Available 0.0116
5006 RNASE4 protein RNASE4 0.0115
4771 Dissimilatory copper-containing nitrite reductase nir 0.0115
4905 Cytochrome c2 Not Available 0.0108
4939 Cytochrome c2 cycA 0.0108
4964 Cytochrome c2 cycA 0.0108
4979 Cytochrome c2 cycA 0.0108
6673 Cytochrome c2 cycA 0.0108
2149 Angiogenin ANG 0.0106
2430 Chondroitinase B cslB 0.0101
6374 Disintegrin and metalloproteinase domain-containing protein 28 ADAM28 0.0089
183 Vascular endothelial growth factor A VEGFA 0.0077
3689 Endoglucanase A celA 0.0023
5411 Slt-IIvB stxB2e 0.0023
5046 Ecotin eco 0.0023
5563 Galectin-2 LGALS2 0.0023
3009 Beta-glucanase Not Available 0.0023
5569 Endo-1,4-beta glucanase EngF engF 0.0023
5565 Inorganic polyphosphate/ATP-glucomannokinase ppgmk 0.0023
5554 D-galactose-binding periplasmic protein mglB 0.0023
3741 D-galactose-binding periplasmic protein precursor mglB 0.0023
5568 Endoglucanase C307 celC307 0.0023
5553 Endoglucanase E1 Acel_0614 0.0023
1875 Pulmonary surfactant-associated protein D SFTPD 0.0023
4668 Laminarinase TM_0024 0.0023
5562 Hexokinase Not Available 0.0023
3744 Endoglucanase SS precursor celS 0.0023
3793 Aspartate ammonia-lyase aspA 0.0023
5559 Neopullulanase nplT 0.0023
4670 Cellulase B celB 0.0023
5570 Endoglucanase E-4 celD 0.0023
4667 BH0236 protein BH0236 0.0023
4671 Endoglucanase C cenC 0.0023
4509 Acetoin(diacetyl) reductase budC 0.002
1184 Interferon beta IFNB1 0.002
5056 Maltooligosyltrehalose trehalohydrolase, putative treZ 0.002
1503 Galectin-7 LGALS7 0.002
2728 Glucan 1,4-alpha-maltotetraohydrolase amyP 0.002
5498 Maltoporin lamB 0.002
5561 Maltoporin lamB 0.002
5247 Endo-1,4-beta-xylanase Not Available 0.002
5248 Endo-1,4-beta-xylanase xlnA 0.002
5250 Endo-1,4-beta-xylanase xyl 0.002
4669 Endo-1,4-beta-xylanase A xynA 0.002
4715 Endo-1,4-beta-xylanase A xlnA 0.002
5560 Endo-1,4-beta-xylanase A xynA 0.002
3525 ADP-ribose pyrophosphatase, mitochondrial NUDT9 0.002
5416 Coat protein VP1 Not Available 0.002
5176 YtnJ moxC 0.002
2705 Dimethyl sulfoxide reductase dmsA 0.002
4819 Hydrolase Not Available 0.0018
5249 Hydrolase Not Available 0.0018
5436 Hydrolase Not Available 0.0018
3091 Maltodextrin phosphorylase malP 0.0018
3547 Enterotoxin type B entB 0.0018
2531 Alpha-amylase amyE 0.0018
2948 Alpha-amylase amy 0.0018
3169 Alpha-amylase Not Available 0.0018
2564 Glucan 1,4-alpha-maltohexaosidase Not Available 0.0018
2856 Glucosamine-6-phosphate isomerase GNPDA1 0.0018
2606 Neopullulanase 2 tvaII 0.0018
2541 Neopullulanase 1 tvaI 0.0018
3747 Cellulase B precursor celB 0.0018
4811 Amylosucrase ams 0.0018
2324 Botulinum neurotoxin type B botB 0.0018
3153 Quinoprotein glucose dehydrogenase-B gdhB 0.0018
4666 Fucose-binding lectin PA-IIL lecB 0.0017
1881 Hexokinase-1 HK1 0.0017
2372 Bifunctional tail protein 9 0.0017
2826 Glucose--fructose oxidoreductase gfo 0.0017
3365 Beta-amylase spoII 0.0017
3225 Shiga toxin B-chain stxB 0.0017
2293 Cyclomaltodextrin glucanotransferase Not Available 0.0016
2508 Cyclomaltodextrin glucanotransferase cgt 0.0016
2523 Cyclomaltodextrin glucanotransferase cgt 0.0016
3207 Cyclomaltodextrin glucanotransferase amyA 0.0016
6614 Lactase-like protein LCTL 0.0016
1675 Glucokinase GCK 0.0016
4662 Glucokinase glk 0.0016
4692 A/G-specific adenine glycosylase mutY 0.0016
2448 Exoglucanase/xylanase [Includes: Exoglucanase cex 0.0016
2802 Endoglucanase G celCCG 0.0016
3668 Maltose-binding periplasmic protein precursor malE 0.0016
2570 Tetanus toxin tetX 0.0016
4272 POSSIBLE CELLULASE CELA1 celA1 0.0016
2440 Endoglucanase F celCCF 0.0015
368 Enoyl-[acyl-carrier-protein] reductase [NADH] inhA 0.0014
3228 Enoyl-[acyl-carrier-protein] reductase [NADH] fabI 0.0014
3678 Enoyl-[acyl-carrier-protein] reductase [NADH] fabI 0.0014
6856 Enoyl-[acyl-carrier-protein] reductase [NADH] fabI 0.0014
2252 Endoglucanase 5A cel5A 0.0014
2245 Xylose isomerase xylA 0.0014
2253 Xylose isomerase xylA 0.0014
2260 Xylose isomerase xylA 0.0014
2431 Xylose isomerase xylA 0.0014
2723 Cholera enterotoxin subunit B ctxB 0.0013
10 Glycogen phosphorylase, liver form PYGL 0.0013
2427 Ferrichrome-iron receptor fhuA 0.0013
1152 Glycogen phosphorylase, muscle form PYGM 0.001
20 Prostaglandin G/H synthase 1 PTGS1 0.0007